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Abstract 
BACKGROUND: The VACTERL association is the non-random occurrence of at least three 
of these congenital anomalies: vertebral, anal, cardiac, tracheo-esophageal, renal, and limb 
anomalies. Diagnosing VACTERL patients is difficult, as many disorders have multiple 
features in common with VACTERL. The aims of this study were to clearly outline component 
features, describe the phenotypic spectrum among the largest group of VACTERL patients thus 
far reported, and to identify phenotypically similar subtypes.  
METHODS: A case-only study was performed assessing data on 501 cases recorded with 
VACTERL in the JRC-EUROCAT central database (birth years: 1980–2015). We 
differentiated between major and minor VACTERL features and anomalies outside the 
VACTERL spectrum to create a clear definition of VACTERL.  
RESULTS: In total, 397 cases (79%) fulfilled our VACTERL diagnostic criteria. The most 
commonly observed major VACTERL features were anorectal malformations and esophageal 
atresia/tracheo-esophageal fistula (both occurring in 62% of VACTERL cases), followed by 
cardiac (57%), renal (51%), vertebral (33%), and limb anomalies (25%), in every possible 
combination. Three VACTERL subtypes were defined: STRICT-VACTERL, VACTERL-
LIKE, and VACTERL-PLUS, based on severity and presence of additional congenital 
anomalies. 
CONCLUSION: The clearly defined VACTERL component features and the VACTERL 
subtypes introduced will improve both clinical practice and etiologic research.  
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Introduction 
In 1973, Quan and Smith described the non-random occurrence of congenital anomalies 
including vertebral anomalies, anorectal malformations (ARM), esophageal atresia with or 
without tracheo-esophageal fistula (EA/TEF), radial anomalies, and renal dysplasia as the 
VATER association[1]. A few years later, cardiac and other limb anomalies were added to the 
spectrum, and the VACTERL association (VACTERL) was clinically confirmed[2,3]. The 
prevalence of VACTERL was 1 in 20,000 births in 2012-2016 according to the EUROCAT 
(European Surveillance of Congenital Anomalies) central database[4]. VACTERL usually 
occurs sporadically, but familial inheritance and increased prevalence of component features in 
first-degree relatives are also observed[5-8]. As the VACTERL etiology is still unknown, 
patients are generally clinically diagnosed when they have three or more VACTERL component 
features, without phenotypic or genetic evidence of an alternative diagnosis[9-11]. However, 
diagnosing these patients can be challenging. First of all, the phenotypic heterogeneity among 
VACTERL cases is large, because any combination of three VACTERL component features 
qualifies for a diagnosis. In addition, other disorders have multiple features in common with 
VACTERL, for example MURCS association, Fanconi anemia, Townes-Brocks syndrome, 
caudal regression syndrome, and CHARGE syndrome[9]. As a result, diagnosing VACTERL 
becomes even more complex. 
In order to obtain clarity about the phenotypic description of VACTERL, several studies 
have examined the frequency of the different component features and combinations of 
component features present among VACTERL cases[7,12-18]. Both the studies of Botto et al. 
and Solomon et al. showed that all VATER/VACTERL component features, except for pre-
axial limb anomalies, were observed in more than 50% of cases[12,17]. Several other studies 
have also focused on component features in VACTERL cases, but because of small study 
populations, the external validity of these study results can be questioned[7,13-16,18]. A 
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detailed description of the classification of congenital anomalies that make up the VACTERL 
components is often missing in literature, which limits the comparison of component feature 
frequencies among studies[19]. However, a detailed description of the classification is 
important, especially since the diagnostic criteria for VACTERL have been debated ever since 
VACTERL was described[1]. Clear guidelines to establishing a VACTERL diagnosis may 
contribute to earlier diagnosis and better management of affected children, and may help 
identify potential subtypes of VACTERL patients in which a different etiology is likely[12]. 
Our study aim was to describe clear diagnostic criteria for VACTERL and to investigate 
the frequency of the VACTERL component features in the largest group of VACTERL cases 
described to date. We describe the phenotypic heterogeneity in cases diagnosed with 
VACTERL obtained from population-based registries and identify phenotypically similar 
subtypes that may be helpful in etiologic research..  
 
Methods 
EUROCAT 
The Joint Research Centre (JRC) - EUROCAT central database, operated by the European 
Commission’s JRC in Ispra, Italy, contains standardized individual data on congenital 
anomalies that are collected by the member registries of the EUROCAT Network[20]. In this 
study, we used data from 29 full member EUROCAT registries in 16 European countries for 
the birth years 1980–2015 (Table 1). The data were ascertained through different data sources, 
such as hospital records, birth and death certificates, maternal questionnaires, and post mortem 
examinations. All congenital anomalies, syndromes, and chromosomal abnormalities were 
coded according to the International Classification of Diseases (ICD) version 9 or 10 with the 
British Paediatric Association (BPA) one digit extension. Some registries also registered 
McKusick codes (also known as OMIM numbers). The data for this study were extracted by 
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the JRC-EUROCAT Central Registry in February 2018. All 29 registries gave approval for 
their data to be included. As this study used anonymous data obtained from registries, it did not 
require ethical’s committee approval.  
 
Questionnaire 
All participating registries received a questionnaire (see Supplemental Information) to obtain 
more detailed information on how VACTERL cases are registered in the specific registry.  
 
Case definitions 
A VATER/VACTERL diagnosis was based on ICD9 codes 759895 and 75989, ICD10 code 
Q8726, and OMIM/McKusick codes 192350, 314390, and 267950. Cases with an ICD9 code 
75989 were only selected when VATER/VACTERL was specified in the text description, as 
this code is not specific for VATER/VACTERL. We included live births, fetal deaths/stillbirths 
(≥20 weeks of gestation), and terminations of pregnancy for fetal anomaly following prenatal 
diagnosis (TOPFA). Fetuses or infants with a diagnosis of VACTERL with hydrocephalus 
(VACTERL-H) were excluded, as VACTERL-H is a distinct condition with a suggested 
autosomal recessive or X-linked inheritance (OMIM %276950). In addition, we excluded cases 
with a  syndrome that explains their phenotype. 
 
VACTERL limits 
We pre-defined a detailed classification of congenital anomalies that were considered to be part 
of VACTERL, in which we made a distinction between major and minor VACTERL features 
(Table 2). Major VACTERL features are congenital anomalies that are part of the classical 
VACTERL features. Minor VACTERL features are congenital anomalies not typically seen in 
VACTERL cases, but occurring in one of the organ systems that are commonly affected among 
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VACTERL cases. The complete rationale behind the inclusion or exclusion of congenital 
anomalies as major or minor VACTERL features is provided in the Supplemental 
Information. In short, we included vertebral anomalies in the non-sacral spine as major 
features and sacral spine anomalies as minor features. All ARM types were included as major 
features, except for cloacal malformations. Most cardiac malformations affecting the cardiac 
chambers and connections or the aorta were included as major features, but anomalies affecting 
the cardiac valves, pulmonary artery, and great veins were considered minor features. All 
EA/TEF types were included as major features. Renal agenesis and other reduction defects of 
the kidneys were included as major features, whereas secondary effects, such as hydronephrosis 
or vesico-uretero-renal reflux were included as minor features. Only the radial-ray anomalies, 
including thumb hypoplasia, were considered major features, while other upper limb anomalies 
were considered minor features. 
In addition, we categorized congenital anomalies that were not considered to be part of 
VACTERL (Supplemental Information Table S1), again divided into major and minor 
congenital anomalies. As we provided a complete overview, not all congenital anomalies were 
necessarily observed within our study population. Minor congenital anomalies were defined 
based on the EUROCAT minor anomalies for exclusion (see chapter 3.2 of EUROCAT Guide 
1.4[21]). All other congenital anomalies were considered major congenital anomalies. , We 
made five exceptions for major congenital anomalies outside the VACTERL spectrum that 
frequently occur simultaneously with major VACTERL features: 1) Tethered cord is often 
observed in combination with ARM, and therefore not included when it occurred in 
combination; 2) Respiratory system anomalies can often be explained by cardiac anomalies, 
EA/TEF, or renal anomalies. Therefore, respiratory system anomalies are considered secondary 
anomalies and consequently, they were not included; 3) As the embryology of the genitourinary 
(GU) system is partly shared with that of the anorectal and renal organ systems, GU anomalies 
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were not considered when they occurred in combination with ARM or renal anomalies; 4) 
Congenital deformities of hip were not included either, as these are very common congenital 
anomalies; 5) Congenital anomalies affecting the lower limbs were not included either, as they 
are often included as limb component features for VACTERL in the clinic.  
 
Predefined VACTERL subtypes 
Individual congenital anomalies reported for the VACTERL cases in this study were judged by 
two independent researchers (M.G. and R.v.d.P) and a clinical geneticist (C.M.). When a case 
had both a major and a minor VACTERL component feature affecting the same organ system, 
only the major VACTERL feature was registered.  
Based on the presence of major and minor VACTERL features, and possibly congenital 
anomalies outside the VACTERL spectrum, the VACTERL cases were subdivided into four 
predefined and mutually exclusive subtypes: 1) STRICT-VACTERL; 2) VACTERL-LIKE; 3) 
VACTERL-PLUS; and 4) NO-VACTERL. The STRICT-VACTERL subtype contains cases 
with ≥3 major VACTERL features and no major congenital anomalies outside the VACTERL 
spectrum, except for the restrictions mentioned above. In the VACTERL-LIKE subtype, we 
included cases with <3 major VACTERL features, but with additional minor VACTERL 
features adding up to ≥3 major and minor VACTERL features combined. Cases with only the 
major VACTERL components ARM and EA/TEF were also included in this subtype. Major 
congenital anomalies outside the VACTERL spectrum were not present in these cases either. 
In the VACTERL-PLUS subtype, we included all cases that fulfilled either the STRICT-
VACTERL or the VACTERL-LIKE subtype criteria, but had additional major congenital 
anomalies outside the VACTERL spectrum. Finally, cases with <3 VACTERL component 
features not included in the VACTERL-LIKE subtype were included in the NO-VACTERL 
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subtype and were excluded from all further analyses. In all subtypes, the cases may have 
additional minor congenital anomalies.  
 
Statistical analysis 
Statistical analyses were performed using SPSS 25.0 (SPSS Inc., Chicago, IL, USA). Infant and 
maternal characteristics assessed were: gender, birth year, birth type (live birth, fetal 
death/stillbirth, TOPFA), survival (>1 week postpartum), gestational age (in completed weeks), 
birth weight (in grams), twin pregnancy (vs. singleton pregnancy),and maternal age at birth (in 
years).  
Descriptive analyses were performed for the frequencies of the VACTERL component 
features and the different combinations of VACTERL component features in the total group of 
VACTERL cases and in the predefined subtypes. In addition, we stratified for gender to see 
whether the phenotypes were different between male and female cases. Chi-squared tests were 
performed to test whether the differences between VACTERL subtypes and between male and 
female cases were statistically significant after Bonferroni correction for the number of 
comparisons (p<0.003, corresponding to 16 tests). .  
In order to identify phenotypes that would cluster together, we performed exploratory 
factor analyses based on principal components for the major VACTERL features and the total 
of major and minor VACTERL features in the total group of VACTERL cases. Clusters 
containing three or more VACTERL features with a minimum factor loading of 0.5 were 
considered clinically relevant.  
 
 
Comparison with the literature 
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We clearly defined all VACTERL component features, within and outside VACTERL 
spectrum, which enabled us to compare our results with the existing literature. For comparison, 
we selected the two largest studies that were published thus far, which included 286 and 60 
VACTERL cases[12,17]. Additionally, we compared our study results with the most recently 
published study that included 36 VACTERL cases[13] and with one of the earliest studies 
including 50 VACTERL cases [3].  
 
Results 
Registries 
In total, 29 EUROCAT registries participated in this study and completed the study 
questionnaire. Overall, there was broad consensus about the registration of VACTERL cases, 
as all registries recorded a VACTERL diagnosis if it was made in the clinic. In one registry, a 
VACTERL diagnosis was also recorded if a case had three or more congenital anomalies being 
part of the VACTERL spectrum. In most registries, the person who makes the clinical diagnosis 
is either pediatrician (N=24) or clinical geneticist (N=26). All registries also code the individual 
congenital anomalies present in the VATER/VACTERL cases. In 16 registries, genetic testing 
is performed to rule out other diagnoses with overlapping features.  
 
Case characteristics 
In total, 545 cases had a VACTERL diagnosis recorded in the central JRC-EUROCAT 
database. After exclusion of 10 cases without information on individual anomalies present, 21 
cases with VACTERL-H, 13 cases with selected syndromes in addition to VACTERL, and 104 
cases that we classified as ‘NO-VACTERL’, 397 cases remained for analyses. The excluded 
syndromes were Fanconi anemia, caudal regression syndrome, Goldenhar syndrome, 
sirenomelia, and the 22q11 deletion syndrome. Of the cases included, 213 cases (54%) were 
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categorized as STRICT-VACTERL, 82 (20%) as VACTERL-LIKE, and 102 (26%) as 
VACTERL-PLUS.  
The characteristics of our study population are listed in Table 3. In the total VACTERL 
group, the majority of cases were male (65%) and more than 75% of the cases were born alive 
between 2000 and 2015. Of these live born cases, 87% survived beyond the first week 
postpartum, 44% were delivered preterm, and 51% had a low birth weight. Among all 
VACTERL cases, 6% were from twin pregnancies, and 18% had a mother aged ≥35 years. 
When we stratified for gender, we observed 4% stillbirths and 22% TOPFAs for male cases 
compared to 2% stillbirths and 17% TOPFAs for female cases (p=0.13). Among male 
compared to female live births, we found lower percentages of preterm deliveries (41% vs. 
48%, p=0.26) and low birth weight (46% vs. 60%, p=0.02).  
Among the different VACTERL subtypes, we observed differences in case 
characteristics, for example, in the percentage of live births, stillbirths, and TOPFAs (p=0.005). 
The most striking differences were seen between VACTERL-LIKE and VACTERL-PLUS for 
live births (92% vs. 69%) and TOPFA (7% vs. 27%). For survival beyond the first week 
postpartum, similar differences were observed among the three subgroups (p=0.002), with 
survival being highest in the VACTERL-LIKE subtype (96%) and lowest in the VACTERL-
PLUS subtype (77%). The latter subtype also included a slightly higher percentage of preterm 
infants (52%) than the other subtypes (41% and 42%; p=0.29). The percentages of cases with 
low birth weight varied between 47% for the STRICT-VACTERL subtype and 57% for the 
VACTERL-PLUS subtype (p=0.38). For twin pregnancies no major differences were observed.  
Maternal age appeared to be lower in the VACTERL-LIKE subtype, with only 10% of mothers 
being ≥35 years old compared to 19% and 22% in the other subtypes, although this difference 
was not statistically significant (p=0.11). 
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Frequencies of congenital anomalies  
VACTERL features 
In the total VACTERL group, the most commonly observed major VACTERL features were 
ARM and EA/TEF (both 62%), followed by cardiac defects (57%), renal defects (51%), 
vertebral defects (33%), and limb defects (25%) (Table 4). When we also included the minor 
VACTERL features, all VACTERL component features were observed in minimally 62% of 
the cases, except for limb anomalies (32%). In the STRICT-VACTERL subtype, the 
percentages of major VACTERL features were much higher than those of minor VACTERL 
features, whereas this was reversed for vertebral anomalies in the VACTERL-LIKE subtype. 
In addition, the percentages of major and minor renal and limb anomalies were almost equal in 
the latter subtype. In the VACTERL-PLUS subtype, EA/TEF was less frequently observed in 
comparison with the two other VACTERL subtypes. Major renal anomalies and minor cardiac 
anomalies were observed more frequently in comparison to the STRICT-VACTERL and 
VACTERL-LIKE subtypes. The percentages of the other VACTERL component features lie 
between that of the STRICT-VACTERL and VACTERL-LIKE subtype.  
In Table 3, we showed that our VACTERL study population contained more male than 
female cases. To study whether the VACTERL phenotypes differed between male and female 
cases, the analyses were stratified by gender (Supplemental Information Table S2). Major 
ARM features were observed less frequently in female (56%) compared to male (65%) cases in 
the total group (p=0.06). This difference became more apparent in the VACTERL-LIKE (36% 
vs. 57%, p=0.07) and VACTERL-PLUS subtypes (43% vs. 61%, p=0.10), although the smaller 
numbers hamper interpretation. In contrast, major cardiac features were observed more 
frequently in female (65%) compared to male (54%) cases in the total group (p=0.03) and in 
the VACTERL-LIKE subtype (50% vs. 28%, p=0.05). Concerning EA/TEF, the percentages 
seemed to be higher for female cases in the VACTERL-PLUS subtype (63% vs. 43%, p=0.06) 
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and lower for female cases in the VACTERL-LIKE subtype (57% vs. 70%; p=0.25). Renal 
anomalies were more frequently observed among male compared to female cases in the 
STRICT-VACTERL subtype (62% vs. 49%, p=0.06), as were limb defects in the VACTERL-
PLUS subtype (31% vs. 13%, p=0.06).  
The component features ARM and EA/TEF are considered core features of VACTERL, 
as these are more specific congenital anomalies with a more clear delineation compared to the 
other VACTERL component features[11,19]. In this study, 358 cases (90%) had either the 
major component features ARM or EA/TEF or both. We observed ARM in 111 cases (28%) 
and EA/TEF in 111 cases (28%), while 136 cases (34%) had both ARM and EA/TEF in the 
total VACTERL group.  
 
Congenital anomalies not part of VACTERL  
Congenital anomalies outside the VACTERL spectrum occurred frequently in our study 
population, as 26% had one or more additional major congenital anomalies (Table 4). By 
definition, these cases were included in the VACTERL-PLUS subtype. Congenital anomalies 
outside the VACTERL spectrum were observed in all organ systems, but the digestive system 
was most often affected, including for example duodenal atresia or malrotation of the colon. 
When we stratified for gender, we did not observe substantial differences in the percentages of 
congenital anomalies outside the VACTERL spectrum (Supplemental Information Table 
S2).  
Tethered cord was observed in nine cases, all in combination with ARM. GU anomalies 
were observed in 63 cases (16%) and in only four of them, the GU anomaly was not present in 
combination with ARM or renal defects. Respiratory anomalies were observed in 11% and 
lower limb anomalies in 13% of the total VACTERL group. If we were to include lower limb 
anomalies within the VACTERL spectrum, 41% of the total population would have had a limb 
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component feature for VACTERL, instead of the 32% of cases with major or minor upper limb 
anomalies reported.  
 
Combinations of VACTERL component features 
In the total group, 69% had three or more major VACTERL features. A triad of major 
VACTERL component features was observed in 49%, a tetrad in 15%, and a pentad in 4%, 
while the full VACTERL spectrum was observed in only one case. In the STRICT-VACTERL 
subtype, we observed a triad of VACTERL component features in 71% of the cases, a tetrad in 
22%, a pentad in 7%, and the full spectrum in one case. Due to the inclusion criteria for the 
VACTERL-LIKE subtype, it did not contain cases with three or more major VACTERL 
features, but in the VACTERL-PLUS subtype, 43% of the cases had a triad, 15% a tetrad, and 
2% a pentad of major VACTERL features.  
Many different combinations of component features were observed in the total group of 
VACTERL cases, illustrating the large heterogeneity (Supplemental Information Table S3). 
Among all combinations, eight combinations of congenital anomalies were observed at or 
above the arbitrary threshold of 10 cases: ACTE, ATER, CTER, ACR , VCTE, VAR, ACTER, 
and VAC, with V the abbreviation for vertebral anomalies, A for ARM, C for cardiac 
anomalies, TE for EA/TEF, R for renal anomalies, and L for limb anomalies. When minor 
VACTERL features were included (Supplemental Information Table S4), new combinations 
of congenital anomalies were observed in 10 or more cases: VCR, VATE, VTER, VACR, 
VATER, VCTER, VACTER, VACRL. Vertebral defects were present among all of these new 
combinations, as a direct result of the vertebral component feature having the highest 
percentage of minor VACTERL features. Logically, ARM or EA/TEF were part of almost 
every combination of congenital anomalies, as these were observed most frequently.  
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In summary, no clear subtypes of phenotypically similar VACTERL cases were 
observed because of the large heterogeneity of combinations of major VACTERL component 
features. These findings were supported by the exploratory factor analyses in which we did not 
identify clusters of three or more major or major and minor VACTERL features.   
 
Comparison with the literature 
When we compared the results of our study with a selection from the literature (Table 5), we 
noticed that: a) most studies did not report the exact congenital anomalies that were included 
among the different component features clearly; b) the frequencies of the component features 
ARM and EA/TEF in our study were quite consistent with that reported in the literature, except 
for the study by Khoury et al. (1983) that reported much lower numbers[3]; and c) the numbers 
of the remaining component features became more comparable with the existing literature when 
we also included the minor VACTERL features.  
 
Discussion 
We aimed to aid clinical practice and etiologic research concerning VACTERL by presenting 
clear guidelines for the diagnosis of VACTERL. Strict diagnostic guidelines for VACTERL 
have been debated ever since VACTERL was described. A European-wide consensus is 
reached amongst participating EUROCAT registries regarding these diagnostic guidelines. We 
showed that a large amount of heterogeneity exists among VACTERL phenotypes, as almost 
every combination of component features is observed. Because of this heterogeneity, no 
phenotypically similar VACTERL subtypes were identified. The VACTERL subtypes 
STRICT-VACTERL, VACTERL-LIKE, and VACTERL-PLUS that were introduced in this 
study were predefined, based on the severity of the congenital anomalies and the presence or 
absence of additional congenital anomalies outside the VACTERL spectrum. These subtypes 
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can be used as subgroups in etiologic studies to aid the identification of genetic and 
environmental risk factors. 
A major strength of this study is its size, as we have included the largest population-
based cohort of European cases with a clinical diagnosis of VACTERL thus far reported. We 
did not assign the VACTERL diagnosis ourselves, but used the clinical diagnosis, registered in 
EUROCAT, to select the cases. The possibility of sampling bias in studies that select cases 
based on the presence of certain core component features, such as ARM or EA/TEF[12] or the 
severity of the phenotype[17], was limited in our study as data from population-based 
congenital anomaly registries were used. 
A limitation of population-based studies is the possibility of incomplete ascertainment 
of VACTERL cases among the participating registries. Cases are registered for monitoring 
purposes and in the event of fetal death or infant death autopsies are not always performed. The 
possibility remains that only the most obvious major congenital anomalies were diagnosed and 
that cases were not screened for additional congenital anomalies that are not immediately 
evident. Therefore, asymptomatic cardiac or renal congenital anomalies, for example, may have 
been missed. This may have resulted in an underrepresentation of certain combinations of 
VACTERL component features and even in cases not being diagnosed with VACTERL at all. 
However, incomplete ascertainment is mitigated in EUROCAT because the registries need to 
adhere to the EUROCAT guidelines and multiple sources are used for ascertainment. In 
addition, data quality indicators (DQIs) are used to assess key elements of the data, including 
completeness of case ascertainment and accuracy of the diagnosis[22]. The DQIs allow 
registries to evaluate their performance in relation to others, provide direction for improvement 
of the data collection and case ascertainment, and allow annual assessments to monitor 
improvement[22].   
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We excluded cases with syndromes that could explain their phenotype. However, only 
16 of the 29 registries indicated that they use genetic testing to rule out other diagnoses with 
overlapping features, such as CHARGE or Townes-Brocks syndrome. In almost half of the 
cases in this study, genetic testing was performed, but this mainly comprised karyotyping or 
the use of chromosomal microarrays. Detailed genetic testing such as whole exome sequencing 
(WES) or whole genome sequencing (WGS) is the only test to confirm the presence of a 
syndrome that has overlap with VACTERL, especially when not all clinical features of the 
syndrome are expressed. WES or WGS was generally not performed at the time the cases were 
registered in EUROCAT, as these genetic tests were not available in the earlier years of the 
registry. Therefore, we cannot rule out that some VACTERL cases in this study have in reality 
genetic evidence of a syndrome  that has multiple features in common with VACTERL. 
However, when genetic testing was performed after initial inclusion of the patient in 
EUROCAT and this resulted in an alternative diagnosis, the diagnoses was usually updated and 
overwrote the VACTERL diagnosis within EUROCAT registries. The VACTERL cases were 
collected in the period 1980–2015, in which diagnostics changed dramatically. Access to 
ultrasound increased the prenatal detection of congenital anomalies and greatly facilitated 
diagnosing VACTERL. The focus of the EUROCAT registries mainly lies on major congenital 
anomalies, as minor congenital anomalies are only registered in EUROCAT when major 
congenital anomalies are present. Therefore, the accuracy of reporting minor congenital 
anomalies is probably not as complete as for major congenital anomalies. On the other hand, 
the majority of cases (>75%) were born or detected between 2000 and 2015, so this will not 
have influenced our study results to a large extent. In addition, we minimized the possible 
impact of the changes in diagnostics by differentiating between major and minor VACTERL 
features and additional anomalies, as minor congenital anomalies are more easily missed.  
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Regarding the study population characteristics, we observed differences compared to 
the literature. We observed a male predominance, with 65% of the cases being male. Male 
predominance was described before[3,7,15], but was never as striking as in this study. However, 
no large differences were observed in the percentages of major and minor component features 
illustrating that VACTERL is not phenotypically different between males and females. In this 
study, 44% of the live born infants were delivered preterm, whereas other studies showed 
percentages between 20 and 33%[3,7,15]. This discrepancy may partly be explained by 
different selection criteria for the cases in previous studies. In our study, but also in that of Oral 
et al., cases were selected based on a final VACTERL diagnosis[15], whereas other studies 
included cases based on the presence of a certain number of component features[3, 7]. Khoury 
et al. found that 54% had a low birth weight, which was comparable to our findings[3].  
We did not detect phenotypically similar subtypes of VACTERL cases based on the 
combination of congenital anomalies present, apart from the clear distinction between the 
predefined VACTERL subtypes. Some differences regarding case characteristics exist among 
these three subtypes, reflecting the complexity and severity of the congenital anomalies. The 
VACTERL-LIKE cases had the highest percentages of live births (92%) and survival beyond 
the first week postpartum (96%) compared to the other VACTERL subtypes, suggesting that 
these cases were less severely affected. The percentages of live births and survival beyond the 
first week postpartum were lowest in the VACTERL-PLUS subtype (67% and 77%). The 
additional anomalies may have resulted in more severely affected cases, and additionally, may 
point towards another possible diagnosis. It can be argued that cases with additional major 
congenital anomalies outside the VACTERL spectrum are not typical VACTERL cases, but 
actually have an undiagnosed syndrome. Therefore, genetic testing to rule out syndromes that 
have overlap with VACTERL is most important in the VACTERL-PLUS subtype. 
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In the comparison of the frequencies of component features between our study and three 
other studies[12,13,17], the percentages of ARM and EA/TEF were similar, most likely because 
these component features are clearly defined congenital anomalies. This is also reflected in the 
low percentages of minor VACTERL features for the ARM and EA/TEF components. 
Vertebral, cardiac, renal, and limb anomalies are less clearly defined, as these comprise a broad 
spectrum of congenital anomalies that differ in severity and in timing of appearance[19]. In 
addition, it is hard to compare frequencies among studies, as the specific congenital anomalies 
included as component features were often not specified. We observed more similarity between 
our study and the literature when we included both major and minor VACTERL features, 
although the latter are not typically seen in VACTERL cases. The comparison with the 
literature, however, seems to indicate that minor VACTERL features are often considered part 
of VACTERL, which increases the heterogeneity of the VACTERL case group unnecessarily. 
This illustrates why clear definitions for the diagnosis of VACTERL are important.   
 GU anomalies were neither considered part of the VACTERL spectrum, nor included 
in VACTERL-PLUS anomalies when occurring in combination with a renal or anorectal 
anomaly, as their embryology is partly shared[23]. Several studies reported relatively high 
frequencies of VACTERL cases with GU anomalies[12,13,23]. Husain et al. even proposed to 
consider another revision of the acronym to include GU anomalies as a component feature of 
VACTERL[13]. As major GU anomalies are less frequently observed than all other VACTERL 
component features, we do not support this extension.   
In conclusion, we present clear guidelines for the congenital anomalies that should be 
considered part of VACTERL, for which consensus was reached. A clear definition of 
VACTERL may help the timely diagnosis of VACTERL cases, improve immediate survival 
and long-term prognosis of children with this condition, and avoid incorrect diagnosis of 
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VACTERL, which is harmful not only for the patient, but also for parents when considering the 
risks in another pregnancy.  
We were not able to identify VACTERL subtypes that show phenotypic similarity, but 
we did present predefined subtypes of VACTERL cases based on the inclusion of major and 
minor VACTERL features and additional congenital anomalies. These more homogeneous 
subtypes may aid the future identification of environmental and genetic risk factors involved in 
the etiology of VACTERL. The VACTERL patient group is very heterogeneous, and it is 
questionable whether all subtypes should be included when studying risk factors. It is important 
to exclude all NO-VACTERL cases, as these cases do not fulfill the diagnostic criteria for 
VACTERL. Furthermore, the STRICT-VACTERL subtype may be the only group of true 
VACTERL patients, and the inclusion of the VACTERL-LIKE and VACTERL-PLUS subtype 
may dilute the magnitude of the risk estimates that are identified in etiologic studies. Therefore, 
we would encourage researchers and physicians to consider using the guidelines and subtypes 
that we provide here, both in the clinic and in future etiologic studies.  
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